iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Use this IBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to iBio, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full IBIO income, balance, and cash tables.